公开所有临床试验数据？监管者的观点。
Open clinical trial data for all? A view from regulators.
机构信息
European Medicines Agency, London, United Kingdom.
出版信息
PLoS Med. 2012;9(4):e1001202. doi: 10.1371/journal.pmed.1001202. Epub 2012 Apr 10.
Abstract
Hans-Georg Eichler from the European Medicines Agency and colleagues provide a view from regulators on access to clinical trial data.
摘要
来自欧洲药品管理局的汉斯-格奥尔格·艾希勒（Hans-Georg Eichler）及其同事从监管机构的角度提供了对临床试验数据获取的看法。
相似文献
1
Open clinical trial data for all? A view from regulators.
PLoS Med. 2012;9(4):e1001202. doi: 10.1371/journal.pmed.1001202. Epub 2012 Apr 10.
2
The imperative to share clinical study reports: recommendations from the Tamiflu experience.
PLoS Med. 2012;9(4):e1001201. doi: 10.1371/journal.pmed.1001201. Epub 2012 Apr 10.
3
Why don't we have all the evidence on oseltamivir?
BMJ. 2009 Dec 8;339:b5351. doi: 10.1136/bmj.b5351.
4
What can we learn from observational studies of oseltamivir to treat influenza in healthy adults?
BMJ. 2009 Dec 8;339:b5248. doi: 10.1136/bmj.b5248.
5
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965. doi: 10.1002/14651858.CD008965.pub3.
6
UK regulators deny claims that their access to oseltamivir trial data was insufficient.
BMJ. 2013 Jun 18;346:f3966. doi: 10.1136/bmj.f3966.
7
Complications: tracking down the data on oseltamivir.
BMJ. 2009 Dec 8;339:b5387. doi: 10.1136/bmj.b5387.
8
Data sharing will pay dividends.
Nature. 2014 Jan 9;505(7482):131. doi: 10.1038/505131a.
9
The Tamiflu saga continues: will our conduct change after the publication of the latest systematic review on benefits and harms of oseltamivir?
Medwave. 2014 May 20;14(4):e5953. doi: 10.5867/medwave.2014.04.5953.
10
Tug of war for antiviral drugs data.
BMJ. 2014 Apr 9;348:g2227. doi: 10.1136/bmj.g2227.
引用本文的文献
1
Sharing Medical Big Data While Preserving Patient Confidentiality in Innovative Medicines Initiative: A Summary and Case Report from BigData@Heart.
Big Data. 2023 Dec;11(6):399-407. doi: 10.1089/big.2022.0178. Epub 2023 Oct 27.
2
Clinical Trial Data Transparency in the EU: Is the New Clinical Trials Regulation a Game-Changer?
IIC Int Rev Ind Prop Copyr Law. 2023;54(5):732-763. doi: 10.1007/s40319-023-01329-4. Epub 2023 May 4.
3
Changes to aspects of ongoing randomised controlled trials with fixed designs.
Trials. 2020 Jun 3;21(1):457. doi: 10.1186/s13063-020-04374-3.
4
Evaluation of Patterns of Presentation, Practice, and Outcomes of Upper Tract Urothelial Cancer: Protocol for an Observational, International, Multicenter, Cohort Study by the Clinical Research Office of the Endourology Society.
JMIR Res Protoc. 2020 Jan 24;9(1):e15363. doi: 10.2196/15363.
5
Open Data Revolution in Clinical Research: Opportunities and Challenges.
Clin Transl Sci. 2020 Jul;13(4):665-674. doi: 10.1111/cts.12756. Epub 2020 Mar 10.
6
Implementing a Cloud Based Method for Protected Clinical Trial Data Sharing.
Pac Symp Biocomput. 2020;25:647-658.
7
Clinical trial data reuse - overcoming complexities in trial design and data sharing.
Trials. 2019 Aug 19;20(1):513. doi: 10.1186/s13063-019-3627-6.
8
Clinical Trial Participants' Views of the Risks and Benefits of Data Sharing.
N Engl J Med. 2018 Jun 7;378(23):2202-2211. doi: 10.1056/NEJMsa1713258.
9
Promoting public access to clinical trial protocols: challenges and recommendations.
Trials. 2018 Feb 17;19(1):116. doi: 10.1186/s13063-018-2510-1.
10
Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology.
Front Med (Lausanne). 2018 Jan 29;5:6. doi: 10.3389/fmed.2018.00006. eCollection 2018.
本文引用的文献
1
Transparency and the Food and Drug Administration--a quantitative study.
J Health Commun. 2013;18(4):391-6. doi: 10.1080/10810730.2012.696229. Epub 2012 Nov 6.
2
The imperative to share clinical study reports: recommendations from the Tamiflu experience.
PLoS Med. 2012;9(4):e1001201. doi: 10.1371/journal.pmed.1001201. Epub 2012 Apr 10.
3
Random treatment assignment using mathematical equipoise for comparative effectiveness trials.
Clin Transl Sci. 2011 Feb;4(1):10-6. doi: 10.1111/j.1752-8062.2010.00253.x.
4
The age-old struggle against the antivaccinationists.
N Engl J Med. 2011 Jan 13;364(2):97-9. doi: 10.1056/NEJMp1010594.
5
The safety of tiotropium--the FDA's conclusions.
N Engl J Med. 2010 Sep 16;363(12):1097-9. doi: 10.1056/NEJMp1008502. Epub 2010 Sep 8.
6
Towards agreement on best practice for publishing raw clinical trial data.
Trials. 2009 Mar 18;10:17. doi: 10.1186/1745-6215-10-17.
7
An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase.
Am J Med. 2002 Aug 1;113(2):104-11. doi: 10.1016/s0002-9343(02)01160-9.
Zotero 插件